| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 08/03/2005 | CN1213061C No.6 bioactive peptide |
| 08/03/2005 | CN1213060C No. 10 bioactive peptide |
| 08/02/2005 | US6924268 Method for inactivating gonadotrophs |
| 08/02/2005 | US6924266 NTP-peptides and method for removal of tumors |
| 08/02/2005 | US6923965 comprises inhibitors of glycosaminoglycans; for wound healing and angiogenesis |
| 08/02/2005 | CA2078539C Process for producing humanized chimera antibody |
| 07/30/2005 | CA2456593A1 Peptides for the diagnosis, monitoring and treatment of diabetes |
| 07/28/2005 | WO2005068492A2 Peptide inhibitors of retroviral integrase useful for the treatment of retroviral infection |
| 07/28/2005 | WO2005068491A1 Antitumoral and antiviral peptides |
| 07/28/2005 | WO2005067648A2 Multiplex spatial profiling of gene expression |
| 07/28/2005 | WO2005009366A3 Restoring vascular function |
| 07/28/2005 | WO2004087734A3 Stq-peptides |
| 07/28/2005 | US20050165225 Novel cytokine isolated from an insect |
| 07/28/2005 | US20050164950 Orally administered small peptides synergize statin activity |
| 07/28/2005 | US20050164949 Renal failure, nephropathy, patent ductus arteriosus, a congenital heart disease; peptide contain the amino acid 4,4'-biphenylalanine; kit for assaying bioactivity of EP4 |
| 07/28/2005 | US20050164948 Methods of treatment with prosaposin-derived peptides |
| 07/28/2005 | US20050164933 Method of reducing injury to mammalian cells |
| 07/28/2005 | US20050164922 Octapeptides, cyclic peptides; treating Cushings Syndrome, gonadotropinoma, hyperparathyroidism, Paget's disease, irritable bowel syndrome, pancreatitis, Crohn's Disease; inhibiting the secretion of growth hormone, insulin; imaging cells |
| 07/28/2005 | US20050164920 Compounds that modulate neuronal growth and their uses |
| 07/28/2005 | US20050164914 erectile dysfunction, and female sexual dysfunction; metallopeptide contains aromatic amino acid side chain moieties and does not bind any melanocortin receptor; combination therapy with phosphodiesterase inhibitor or melanocortin receptor MC4-R agonist |
| 07/28/2005 | US20050164515 Biological control of nanoparticle nucleation, shape and crystal phase |
| 07/28/2005 | US20050164363 Acetolactate synthase mixture for identifying modulators of bacterial infection; bactericides; microbiocides |
| 07/28/2005 | US20050164311 Biological assay detection method |
| 07/28/2005 | US20050164182 Nucleoside comprising reporter molecule cleavable by hydrolase such as esterases, phosphatases, peptidases, penicillin amidases, glycosidases, and phosphorylases; limits polymerase activity; sequencing; solid phase synthesis |
| 07/28/2005 | US20050163786 Compounds and methods for modulating adhesion molecule function |
| 07/28/2005 | US20050163710 Gastrin receptor-avid peptide conjugates |
| 07/28/2005 | DE10360435A1 New antibiotic peptides, useful in treating or preventing a microbial or viral infections or in inactivating Gram-positive and -negative bacteria, protozoa, fungi and virus |
| 07/28/2005 | CA2554001A1 Epitope/peptide recognized by hla-a2402-restricted ep-cam-specific ctl and use of the same |
| 07/27/2005 | EP1557431A1 Assay and reagents for quantifying hBNP |
| 07/27/2005 | EP1556074A2 Casein derived peptides and uses thereof in therapy |
| 07/27/2005 | EP1556067A2 Phenolic binding peptides |
| 07/27/2005 | EP0920510B1 GnRH-LEUKOTOXIN CHIMERAS |
| 07/27/2005 | CN1646564A 修饰的因子Ⅷ Modification factor Ⅷ |
| 07/27/2005 | CN1646563A Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/27/2005 | CN1646160A Anti-alpha V beta 6 antibodies |
| 07/26/2005 | US6921806 Peptide |
| 07/26/2005 | US6921805 Neo-tryptophan-containing neurotension polypeptide analogs having enhanced biological effects as compared to NT itself; antinociception/anorexogenic agents; induction of thirst, hypothermia, weight loss, appetite; psychological disorders |
| 07/26/2005 | US6921749 Polypeptides derived from endostatin exhibiting antiangiogenic activity |
| 07/26/2005 | US6921645 Antibodies to chemokine β-4 |
| 07/26/2005 | US6921531 Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy |
| 07/26/2005 | US6921526 Gastrin receptor-avid peptide conjugates |
| 07/26/2005 | CA2294562C Hepatitis c inhibitor peptide analogues |
| 07/26/2005 | CA2143823C Retro-, inverso - and retro-inverso synthetic peptide analogues |
| 07/21/2005 | WO2005066867A2 Modulators of cell-surface receptors of the ig-class |
| 07/21/2005 | WO2005066633A2 Fluorescent ligands for gpcr arrays |
| 07/21/2005 | WO2005066201A1 Amino acid sequences from active principle of musk and their acetic salt, also the preparation and usage |
| 07/21/2005 | WO2005066200A1 Novel peptide, process for producing the same and pharmaceutical composition containing the peptide |
| 07/21/2005 | WO2005011607A3 Treatment of cancers expressing p95 erbb2 |
| 07/21/2005 | WO2003074005A8 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 07/21/2005 | US20050159360 Improved bioavailability |
| 07/21/2005 | US20050159359 Methods and compositions for derepression of IAP-inhibited caspase |
| 07/21/2005 | US20050159346 Cyclic peptide antitumor agents |
| 07/21/2005 | US20050159343 Inhibitors of glycosaminoglycans |
| 07/21/2005 | US20050158838 Novel enterokinase cleavage sequences |
| 07/21/2005 | US20050158766 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples |
| 07/21/2005 | US20050158744 Microarray comprising preferential oligonucleotides for use in drug screening and disease diagnosis |
| 07/21/2005 | US20050158370 Charge-balanced chemoselective linkers |
| 07/21/2005 | US20050158309 Gonadotropin-releasing hormone (gnrh); gene expression inhibition; for treatment of T-cell related neoplastic diseases |
| 07/21/2005 | DE10358824A1 Antibakterielle Makrozyklen mit substituiertem Biphenyl Antibacterial macrocycles with substituted biphenyl |
| 07/21/2005 | CA2552188A1 Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof |
| 07/21/2005 | CA2550854A1 Membranes incorporating recognition moieties |
| 07/20/2005 | EP1554306A2 Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy |
| 07/20/2005 | EP1554305A1 Prion protein-binding peptide sequences |
| 07/20/2005 | EP1401467A4 Alpha-fetoprotein peptides and uses thereof |
| 07/20/2005 | EP1229965B1 Placental human neurokinin b precursor |
| 07/20/2005 | EP1185493B1 Quinones for treatment of diseases |
| 07/20/2005 | CN1642978A Peptides and peptidommetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 07/20/2005 | CN1642568A Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
| 07/20/2005 | CN1642566A Chimeric hybrid analgesics |
| 07/20/2005 | CN1640889A Method for synthesizing thymic-pentapeptide by mixing acid anhydride method |
| 07/19/2005 | US6919426 Peptides and related molecules that modulate nerve growth factor activity |
| 07/19/2005 | US6919425 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 07/19/2005 | US6919424 Comprises polypeptide for, diagnosis, detection and treatment of cancer |
| 07/19/2005 | US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 07/19/2005 | US6919211 Solid support comprising amino acid sequences for sequencing, fingerprinting and mapping biological macromolecules; structure and function analysis |
| 07/19/2005 | US6919188 Pseudomycin production by Pseudomonas syringae |
| 07/19/2005 | US6919080 Polypeptide for use in the treatment of respiratory disorders in poultry |
| 07/14/2005 | WO2005063796A1 Inhibitors of amyloid precursor protein processing |
| 07/14/2005 | WO2005056043A3 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 07/14/2005 | WO2005012502A3 Methods of identifying optimal variants of peptide epitopes |
| 07/14/2005 | WO2005000871A3 Peptides antagonistic to an anti-angiogenic antibody and uses therefor |
| 07/14/2005 | WO2004111084A3 Peptides enhancing ceh activity or inhibiting acat activity, pharmaceutical compositions comprising these peptides and their use in the treatment of atherosclerosis |
| 07/14/2005 | US20050154188 Cytoplasmic tranduction peptides and uses thereof |
| 07/14/2005 | US20050153900 Novel inhibitors of hepatitis C virus NS3/NS4a serine protease |
| 07/14/2005 | US20050153894 capable of inhibiting cyclin dependent kinases (CDK) or cyclin complexes, used in the treatment of proliferative disorders such as cancers and leukemias |
| 07/14/2005 | US20050153888 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/14/2005 | US20050153876 Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 07/14/2005 | US20050153374 Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes |
| 07/14/2005 | US20050153363 Polymer arrays |
| 07/14/2005 | US20050153362 Polymer arrays |
| 07/14/2005 | US20050152985 The use of Colostrinin as a medicament, particularly in the treatment of chronic disorders of the central nervous system and the immune system. |
| 07/14/2005 | CA2550651A1 Novel anti-il 13 antibodies and uses thereof |
| 07/13/2005 | EP1553171A1 Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them |
| 07/13/2005 | EP1553168A2 Methods for selectively stimulating proliferation of T cells |
| 07/13/2005 | EP1552309A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A CLLD8 PROTEIN |
| 07/13/2005 | EP1551959A2 Modulators of chloride intracellular channel 1 protein signaling |
| 07/13/2005 | EP1551867A2 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
| 07/13/2005 | EP1551762A2 Peptide derivatives, and their use for the synthesis of silicon-based composite materials |
| 07/13/2005 | EP1551449A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 07/13/2005 | EP1551439A2 Improved systems and methods for analysis of protein post-translational modification |